ORIGINAL ARTICLE
Histopathological factors influencing results of combined treatment in patients with laryngeal cancer
More details
Hide details
Publication date: 2015-10-23
Pol J Pathol 2015;66(3):260-268
KEYWORDS
ABSTRACT
The aim of the study was to assess the prognostic value of postoperative histopathological factors as well as the clinical usefulness of the modified risk score for recurrence.
In a group of 197 patients with laryngeal cancer who underwent surgery followed by radiation therapy, partial resection was performed in 21.5% of patients and total resection in 78.5%. The majority of patients had T3 or T4 (74%) and N0 (63%) cancer. Macroscopically positive margins were reported in 10% of patients after partial resection and in 7% of patients after total resection, whereas microscopically positive margins were observed in 31% and 20% of cases, respectively. Extracapsular extension was observed in 22% of patients. In order to estimate local and nodal recurrence risk rates, criteria developed by Peters were used. Five-year local control (LC) was achieved in 88% of patients, disease-free survival (DFS) in 68% of patients and overall survival (OS) in 73% of patients. In the case of macroscopically positive margins, the 5-year DFS was 33% lower compared to radical surgery and 25% lower in the case of microscopically positive margins. The 5-year DFS was reduced by 29% due to extracapsular extension. Cox model analysis indicated that the degree of recurrence risk was the most potent independent prognostic factor for postoperative radiation therapy in laryngeal cancer.
Negative histopathological factors influencing results of combined treatment of laryngeal cancer include macro- and microscopically positive margins, neck lymph node involvement and extracapsular extension.
REFERENCES (54)
1.
Barkley HT, Fletcher GH, Jesse RH, et al. Management of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 1972; 124: 462-467.
2.
Bartelink H, Breur K, Hart G, et al. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer 1983; 52: 1003-1008.
3.
Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancer. Cancer Treat Rep 1975; 2: 177-191.
4.
Dinapoli N, Parrilla C, Galli J, et al. Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol 2010; 186: 607-613.
5.
Feldman M, Fletcher GH. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinoma of the oral cavity or oropharynx. Int J Radiat Oncol Biol Phys 1982; 8: 27-30.
6.
Hoebers F, Rios E, Troost E, et al. Definitive radiation therapy for treatment of laryngeal carcinoma: impact of local relapse on outcome and implications for treatment strategies. Strahlenther Onkol 2013; 189: 834-841.
7.
Marcus RB, Million RR, Cassissi NJ. Postoperative irradiation for squamous cell carcinomas of the head and neck: Analysis of time-dose factors related to control above the clavicle. Int J Radiat Oncol Biol Phys 1979; 5: 1943-1949.
8.
Mucha-Małecka A, Składowski K. High-dose radiotherapy alone for patients with T4-stage laryngeal cancer. Strahlenther Onkol 2013; 189: 632-638.
9.
Rades D, Meymers T, Kazic N, et al. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck. A matched-pair analysis. Strahlenther Onkol 2011; 187: 541-547.
10.
Vikram B, Strong EW, Shah JP, et al. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984; 6: 720-723.
11.
Ang KK, Garden AS. Radiotherapy for head and neck cancers. Lippincott, Philadelphia 2002; 105-121.
12.
Fletcher GH. Larynx. In: Textbook of Radiotherapy. 3rd. ed. Fletcher GH (ed.). Lea & Febiger, Philadelphia 1980; 201-228.
13.
Looser KG, Shah JP, Strong EN. The significance of positive margins in marginally resected epidermoid carcinoma. Head Neck Surg 1978; 1: 107-111.
14.
Lee NK, Goegfert H, Wendt CD. Supraglottic laryngectomy for intermediate stage cancer: U.T.M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope 1990; 100: 831-836.
15.
Strong WW. Sites of treatment failure in head and neck cancer. Cancer Treat Symp 1983; 2: 5-20.
16.
Rubin J, Johnson JT, Myers EN. Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 1990; 103: 805-812.
17.
Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3-11.
18.
Amdur RJ, Parsons JT, Mendenhall WM, et al. Postoperative irradiation for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989; 16: 25-36.
19.
Awwad HK, Khafaagy Y, Barsoum M, et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumor proliferation. Radiother Oncol 1992; 25: 261-266.
20.
Danilidis J, Nikolaou A, Fountzilas G, et al. Vertical partial laryngectomy: our results after treating 81 cases of T2 and T3 laryngeal carcinomas. J Laryngol Otol 1992; 106: 349-352.
21.
Hirabayashi H, Koshii K, Uno K, et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope 1991; 101: 502-506.
22.
Meredith APD, Randall CJ, Shaw HJ. Advanced laryngeal cancer: a management perpective. J Laryng Otol 1987; 101: 1046-1054.
23.
Soo KC, Shah JP, Gopinath KS, et al. Analysis of prognostic variables and results after vertical partial laryngectomy. Amer J Surg 1988; 156: 264-268.
24.
Suarez C, Rodrigo JP, Herranz J, et al. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol 1995; 104: 358-363.
25.
Lindberg RD, Jesse RH. Treatment of cervical lymph node metastasis from primary lesions of the oropharynx, supraglottic larynx and hypopharynx. Am J Roentgenol Radium Ther Nucl Med 1968; 102: 132-137.
26.
Weems DH, Mendenhall WM, Parsons JT, et al. Squamous cell carcinoma of the supraglottic larynx treated with surgery and/or radiation therapy. Int J Radiat Oncol Biol Phys 1987; 13: 1483-1487.
27.
Mittal B, Mariks JE, Ogura JH. Transglottic carcinoma. Cancer 1984; 53: 151-161.
28.
Layland MK, Sessions GE, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx and hypopharynx: N0 versus N+. Laryngoscope 2005; 115: 629-639.
29.
Hinerman RW, Morris CG, Amur MJ, et al. Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx. Am J Clin Oncol 2006; 29: 613-621.
30.
Smee RI, De-loyde KJ, Broadley K, et al. Prognostic factors for supraglottic cancer; importance of the unfit patient. Head Neck 2013; 35: 949-958.
31.
Akman FC, Dag N, Ataman OU, et al. The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy. Eur Arch Otorhinolaryngol 2008; 265: 1245-1255.
32.
Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 1987; 13: 833-837.
33.
Cook JA, Jones AS, Philips DE, et al. Implications of tumour in resection margins following surgical treatment of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci 1993; 18: 37-41.
34.
Fu KK, Hammond E, Pajak TF, et al. Flow cytometric quantification of the proliferation – associated nuclear antigen p105 and DNA content in advanced head and neck cancers: results of RTOG 91-08. Int J Radiat Oncol Biol Phys 1994; 29: 661-671.
35.
Huang D, Johnson ChR, Schmidt-Ullrich RK, et al. Incompletely resulted advanced sguamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs. salvage radiotherapy. Radiother Oncol 1992; 24: 27-93.
36.
Jacobs JR, Sessions DC, Ogura JH. Recurrent carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg 1980; 88: 425-433.
37.
Parsons JT, Mendenhall WM, Stringer SP, et al. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 1997; 39: 137-148.
38.
Wang ZH, Million RR, Mendenhall WM, et al. Treatment with preoperative irradiation and surgery of squamous cell carcinoma of the head and neck. Cancer 1989; 64: 32-38.
39.
Zalefsky MJ, Harrison LB, Fass DE, et al. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1992; 25: 17-21.
40.
Snyderman NL, Johnson JT, Schramm VL, et al. Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer 1985; 56: 1597-1599.
41.
Prabhu RS, Hanasoge S, Magliocca KR, et al. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. Cancer 2014; 120: 1499-1506.
42.
Oosterkamp S1, de Jong JM, Van den Ende PL, et al. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Laryngoscope 2006; 116: 2067-2070.
43.
Snow JB, Gelber RD, Kremer S, et al. Comparison of preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck. Acta Otolaryngol 1981; 91: 611-626.
44.
Maillard S, Jovenin N, Cauchois A, et al. Postoperative radiotherapy in N0 laryngeal cancer. Cancer Radiother 2005; 9: 285-292.
45.
Pradier R, Gonzalez A, Matos E, et al. Prognostic factors in laryngeal carcinoma. Experience in 296 male patients. Cancer 1993; 71: 2472-2476.
46.
Keim WF, Shapiro MJ, Rosin HD, et al. Study of postlaryngectomy stomal recurrence. Arch Otolaryngol Head Neck Surg 1965; 81: 183-186.
47.
Rockley TJ, Powell J, Robin PE, et al. Post-laryngectomy stomal recurrence: tumour implantation or paratracheal lymphatic metastasis? Clin Otolaryngol 1991; 16: 43-47.
48.
Herchenhorn D, Dias FL, Ferreira CG, et al. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. ORL J Otorhinolaryngol Relat Spec 2008; 70: 381-388.
49.
Arriagada R, Eschwege F, Cachin Y, et al. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983; 51: 1819-1825.
50.
Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
51.
Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004; 59: 28-42.
52.
Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312-321.
53.
Daly ME, Lieskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007; 29: 211-20.
54.
Chen AM, Farwell DG, Luu Q, et al. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2011; 80: 1423-1429.